4basebio (LSE:4BB) FCF Yield %: -21.19 (As of Jun. 30, 2026)


LSE:4BB 4basebio PLC LSE:4BB
61 GF Score
Price £5.25
GF Value £28.18
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is 4basebio FCF Yield %?

4basebio LSE:4BB 61 FCF Yield % is -21.19 as of Jun. 30, 2026. GuruFocus rates LSE:4BB with a GF Score™ of 61/100 and a GF Value™ of £28.18 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,415 Biotechnology companies, 4basebio ranks worse than 68.06% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, 4basebio's Trailing 12-Month Free Cash Flow is £-17.23 Mil, and Market Cap is £81.30 Mil. Therefore, 4basebio's FCF Yield % for today is -21.19%.

The historical rank and industry rank for 4basebio's FCF Yield % or its related term are showing as below:

LSE:4BB' s FCF Yield % Range Over the Past 10 Years
Min: -25.53   Med: -7.43   Max: -2
Current: -21.19


During the past 7 years, the highest FCF Yield % of 4basebio was -2.00%. The lowest was -25.53%. And the median was -7.43%.

LSE:4BB's FCF Yield % is ranked worse than
68.06% of 1415 companies
in the Biotechnology industry
Industry Median: -9.49 vs LSE:4BB: -21.19

4basebio's FCF Margin % for the quarter that ended in Dec. 2025 was -1,622.93%.


4basebio FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


4basebio FCF Yield % Related Terms


4basebio FCF Yield % Historical Data

* Premium members only.

The historical data trend for 4basebio's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4basebio FCF Yield % Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial -5.61 -7.60 -9.15 -6.58 -18.09

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.42 -5.92 -6.92 -11.54 -17.69

LSE:4BB vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, 4basebio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4basebio FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's FCF Yield % distribution charts can be found below:

* The bar in red indicates where 4basebio's FCF Yield % falls into.


LSE:4BB
61GF Score
4basebio PLC LSE:4BB
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4basebio FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

4basebio's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-17.227 / 95.23275
=-18.09%

4basebio's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-8.423 * 2 / 95.23275
=-17.69%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -21.19 mean?
4basebio (LSE:4BB) has a FCF Yield % of -21.19 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on 4basebio and its competitors. According to the industry distribution chart, 4basebio ranks #963 out of 1415 companies in the Biotechnology industry, placing it in the top 68.1%.
Is 4basebio's FCF Yield % too high?
4basebio's current FCF Yield % is -21.19. Based on the distribution chart, 4basebio ranks #963 out of 1415 companies in the Biotechnology industry, which is below the industry midpoint. Overall, 4basebio has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 4basebio's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, 4basebio ranks #963 out of 1415 companies for FCF Yield %. This places 4basebio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on 4basebio and its competitors. 4basebio's current FCF Yield % is -21.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4basebio stock overvalued right now?
Based on GuruFocus' analysis, 4basebio (LSE:4BB) is currently considered Possible Value Trap. The stock's GF Value™ is £28.18, compared to a current price of £5.25 — trading 81.4% below its estimated fair value. The current FCF Yield % is -21.19. 4basebio's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For 4basebio (LSE:4BB), the current FCF Yield % is -21.19 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 4basebio (LSE:4BB) Overvalued in 2026?

Based on GuruFocus' analysis, 4basebio stock appears to be undervalued. The current stock price of £5.25 is trading 81.4% below its estimated GF Value™ of £28.18. GuruFocus considers 4basebio to be Possible Value Trap.

Key valuation signals for LSE:4BB:

  • FCF Yield %: -21.19
  • GF Value™: £28.18 vs. price of £5.25 (81.4% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the LSE:4BB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


4basebio Business Description

Other Exchanges 88Q:Germany
Address 25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effectively and safely delivering these DNA-based products to patients. The company operates across three geographic segments: Europe, the United States, and the Rest of the World, with the majority of its revenue generated from the United States.
61GF Score

Get the complete analysis for LSE:4BB

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£5.25
Price
£28.18
GF Value